PT1282604E - Carbonatos e éteres caprolactâmicos substituídos e seu uso como agentes anti-tumorais - Google Patents

Carbonatos e éteres caprolactâmicos substituídos e seu uso como agentes anti-tumorais Download PDF

Info

Publication number
PT1282604E
PT1282604E PT01975824T PT01975824T PT1282604E PT 1282604 E PT1282604 E PT 1282604E PT 01975824 T PT01975824 T PT 01975824T PT 01975824 T PT01975824 T PT 01975824T PT 1282604 E PT1282604 E PT 1282604E
Authority
PT
Portugal
Prior art keywords
ethers
tumor agents
compounds
substituted caprolactam
carbonates
Prior art date
Application number
PT01975824T
Other languages
English (en)
Inventor
Kenneth Walter Bair
Richard William Versace
Frederick Ray Kinder Jr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1282604E publication Critical patent/PT1282604E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT01975824T 2000-05-11 2001-05-09 Carbonatos e éteres caprolactâmicos substituídos e seu uso como agentes anti-tumorais PT1282604E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56866700A 2000-05-11 2000-05-11

Publications (1)

Publication Number Publication Date
PT1282604E true PT1282604E (pt) 2008-04-11

Family

ID=24272224

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01975824T PT1282604E (pt) 2000-05-11 2001-05-09 Carbonatos e éteres caprolactâmicos substituídos e seu uso como agentes anti-tumorais

Country Status (11)

Country Link
EP (1) EP1282604B1 (pt)
JP (1) JP2003532711A (pt)
CN (1) CN1191237C (pt)
AT (1) ATE383341T1 (pt)
AU (1) AU2001295206A1 (pt)
BR (1) BR0110641A (pt)
CA (1) CA2405892C (pt)
DE (1) DE60132324T2 (pt)
ES (1) ES2299515T3 (pt)
PT (1) PT1282604E (pt)
WO (1) WO2001085697A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0412843A (pt) 2003-07-25 2006-09-26 Novartis Ag lactamas substituìdas e uso das mesmas como agentes anticáncer
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2901555A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) * 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831135A (en) * 1986-06-18 1989-05-16 The Regents Of The University Of California Bengamide anthelmintics
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores

Also Published As

Publication number Publication date
DE60132324T2 (de) 2008-12-24
CN1191237C (zh) 2005-03-02
ES2299515T3 (es) 2008-06-01
CA2405892A1 (en) 2001-11-15
AU2001295206A1 (en) 2001-11-20
DE60132324D1 (de) 2008-02-21
EP1282604A1 (en) 2003-02-12
CN1429213A (zh) 2003-07-09
EP1282604B1 (en) 2008-01-09
CA2405892C (en) 2009-07-07
JP2003532711A (ja) 2003-11-05
BR0110641A (pt) 2003-03-18
WO2001085697A1 (en) 2001-11-15
ATE383341T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
NL350075I2 (pt)
DE60112609D1 (en) Pyrazolopyridine
MXPA03004780A (es) Nuevas sulfamidas.
HK1048990A1 (en) Novel compounds.
MY136520A (en) Novel compounds
MY127718A (en) Dolastatin 10 derivatives.
DE60116761D1 (en) Adamantanderivate
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
MXPA02012271A (es) Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor.
AU2003228770A8 (en) Substituted pyrazolopyrimidines
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
AU2002239348A1 (en) Pyrazolopyridine derivatives
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
PT1282604E (pt) Carbonatos e éteres caprolactâmicos substituídos e seu uso como agentes anti-tumorais
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
IL137489A0 (en) Pharmaceutical compositions containing inhibitors of the lymphotoxin pathway
MXPA02012426A (es) Compuestos nuevos.
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA03005374A (es) Carbazoles antitumorales.
YU72802A (sh) Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
MXPA04004450A (es) Nuevos compuestos y composiciones como inhibidores de catepsina s.
IL138638A0 (en) Processes for preparing intermediates
AP2002002494A0 (en) Hygromycin derivatives.